Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.0999
+0.0229 (29.74%)
Aug 15, 2025, 9:30 AM EDT
Altamira Therapeutics Market Cap
Altamira Therapeutics has a market cap or net worth of $570.98 thousand as of August 15, 2025. Its market cap has decreased by -82.47% in one year.
Market Cap
570.98K
Enterprise Value
-66.60K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 570.98K, a decrease of -99.67%. That is a compound annual growth rate of -40.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 570.98K | 51.91% |
| Dec 31, 2024 | 375.87K | -72.84% |
| Dec 29, 2023 | 1.38M | -75.59% |
| Dec 30, 2022 | 5.67M | -78.93% |
| Dec 31, 2021 | 26.91M | -10.02% |
| Dec 31, 2020 | 29.91M | 459.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 608.19M |
| Glass House Brands | 543.74M |
| American Oncology Network | 393.37M |
| Northwest Biotherapeutics | 332.06M |
| CytoDyn | 300.87M |